StockData
XBiotech Inc. logo

XBiotech Inc. (XBIT) stock

XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.85−0.11 (-5.61%)

Close on Nov 16, 2026Market cap $56.40MP/E –Yield –

XBiotech operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

XBiotech's operating cash flow for the twelve months ending Jun 30, 2026 was -$40.70M. For fiscal 2025 it was -$39.92M. The highest annual figure on record is $69.45M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$39.92M–
FY2024Dec 31, 2024-$30.96M–
FY2023Dec 31, 2023-$18.73M–
FY2022Dec 31, 2022-$14.82M-121.3%
FY2021Dec 31, 2021$69.45M–
FY2020Dec 31, 2020-$65.15M–
FY2019Dec 31, 2019-$18.27M–
FY2018Dec 31, 2018-$16.54M–
FY2017Dec 31, 2017-$33.65M–
FY2016Dec 31, 2016-$46.02M–
FY2015Dec 31, 2015-$33.31M–
FY2014Dec 31, 2014-$11.70M–
FY2013Dec 31, 2013-$8.91M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.52M–
Q1 FY2026Mar 31, 2026-$8.97M–
Q4 FY2025Dec 31, 2025-$22.95M–
Q3 FY2025Sep 30, 2025-$4.26M–
Q2 FY2025Jun 30, 2025-$5.99M–
Q1 FY2025Mar 31, 2025-$6.72M–
Q4 FY2024Dec 31, 2024-$6.54M–
Q3 FY2024Sep 30, 2024-$5.85M–
Q2 FY2024Jun 30, 2024-$11.38M–
Q1 FY2024Mar 31, 2024-$7.20M–
Q4 FY2023Dec 31, 2023-$3.43M–
Q3 FY2023Sep 30, 2023-$1.49M–
Q2 FY2023Jun 30, 2023-$9.00M–
Q1 FY2023Mar 31, 2023-$4.81M–
Q4 FY2022Dec 31, 2022-$3.16M–
Q3 FY2022Sep 30, 2022-$1.15M–
Q2 FY2022Jun 30, 2022-$5.39M-107.4%
Q1 FY2022Mar 31, 2022-$5.12M-383.2%
Q4 FY2021Dec 31, 2021-$1.76M–
Q3 FY2021Sep 30, 2021-$3.40M-145.5%
Q2 FY2021Jun 30, 2021$72.80M–
Q1 FY2021Mar 31, 2021$1.81M–
Q4 FY2020Dec 31, 2020-$391.00K–
Q3 FY2020Sep 30, 2020$7.48M–
Q2 FY2020Jun 30, 2020-$11.57M–
Q1 FY2020Mar 31, 2020-$60.67M–
Q4 FY2019Dec 31, 2019-$3.75M–
Q3 FY2019Sep 30, 2019-$4.98M–
Q2 FY2019Jun 30, 2019-$4.86M–
Q1 FY2019Mar 31, 2019-$4.68M–
Q4 FY2018Dec 31, 2018-$5.12M–
Q3 FY2018Sep 30, 2018-$4.00M–
Q2 FY2018Jun 30, 2018-$3.90M–
Q1 FY2018Mar 31, 2018-$3.53M–
Q4 FY2017Dec 31, 2017-$6.81M–
Q3 FY2017Sep 30, 2017-$6.47M–
Q2 FY2017Jun 30, 2017-$8.47M–
Q1 FY2017Mar 31, 2017-$11.91M–
Q4 FY2016Dec 31, 2016-$12.80M–
Q3 FY2016Sep 30, 2016-$15.02M–

More XBiotech figures

See a number that looks wrong?